• Nausea

Sancuso Generic Name & Formulations

General Description

Granisetron 3.1mg/24hrs; transdermal delivery system (patch).

Pharmacological Class

5-HT3 receptor antagonist.

How Supplied


Sancuso Indications


Prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.

Sancuso Dosage and Administration


≥18yrs: apply one patch to clean, dry, intact healthy skin on upper outer arm 24 to 48 hours before chemotherapy; remove at least 24 hours after chemotherapy is completed. May wear patch for up to 7 days. Do not cut patch.


<18yrs: not recommended.

Sancuso Contraindications

Not Applicable

Sancuso Boxed Warnings

Not Applicable

Sancuso Warnings/Precautions


May mask progressive ilieus and/or gastric distention. Avoid direct sun or UV light (cover patch with clothing during use and for 10 days after removing patch). Avoid exposure to external heat sources (eg, heating pads). Pregnancy (Cat.B). Nursing mothers.

Sancuso Pharmacokinetics

See Literature

Sancuso Interactions


Do not take with other granisetron products. Serotonin syndrome possible esp. with concomitant serotonergic drugs.

Sancuso Adverse Reactions

Adverse Reactions

Constipation; local irritation (remove patch if severe or if generalized skin reaction occurs), headache; serotonin syndrome (discontinue if occurs).

Sancuso Clinical Trials

See Literature

Sancuso Note

Not Applicable

Sancuso Patient Counseling

See Literature